Friday, October 7, 2022
7:30 PM – 7:45 PM MT – Registration/Dinner
7:45 PM – 8:45 PM MT – Symposium
Gaylord Rockies Resort & Convention Center
6700 North Gaylord Rockies Boulevard
Aurora, CO 80019
Meeting Location: Summit 6-7
- Whiteboard and 2D animations
- Interactive, case-based learning environment
- Create your own Personalized Poster
Emily S. Ruiz, MD, MPH
Assistant Professor of Dermatology Harvard Medical School
Academic Director, Micrographic Surgery Center
Brigham and Women’s Hospital
Director, High-Risk Skin Cancer Clinic Dana-Farber Cancer Center
After completing the CME activity, learners should be better able to:
- Interpret data supporting the use of new systemic therapies for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation
- Select patients with unresectable NMSCs who may derive greater benefit from new systemic therapies as opposed to Mohs surgery
- Cultivate close working relationships with other members of interdisciplinary care teams for the management of patients with advanced NMSCs failing or not amenable to surgery or radiation
This CME initiative is designed to meet the educational needs of surgical dermatologists, Mohs surgeons, dermatologists and other healthcare practitioners who care for patients with advanced/mBCC or CSCC.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity was planned and produced in accordance with ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at firstname.lastname@example.org.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com